Ion channels as molecular targets of glioblastoma electrotherapy

Therapies with weak, non-ionizing electromagnetic fields comprise FDA-approved treatments such as Tumor Treating Fields (TTFields) that are used for adjuvant therapy of glioblastoma. In vitro data and animal models suggest a variety of biological TTFields effects. In particular, effects ranging from...

Descripción completa

Detalles Bibliográficos
Autores principales: Abed, Tayeb, Ganser, Katrin, Eckert, Franziska, Stransky, Nicolai, Huber, Stephan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064067/
https://www.ncbi.nlm.nih.gov/pubmed/37006466
http://dx.doi.org/10.3389/fncel.2023.1133984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064067/
https://www.ncbi.nlm.nih.gov/pubmed/37006466
http://dx.doi.org/10.3389/fncel.2023.1133984

Ejemplares similares